BellRing Q3 net sales $370.6M (+8.2%), adj. EBITDA $80.8M; updates FY2022 guidance

BELLRING BRANDS, INC.

2022-Q3 EPS reported $0.61 revenue$992,300,000

Q3 net sales $370.6M (+8.2% YoY); Premier Protein +7.3% (volumes -9.4%), Dymatize +16.8% (volumes -28.0%).
GAAP diluted EPS $0.29; adjusted diluted EPS $0.31.
Adjusted EBITDA $80.8M (+14.6% YoY); nine-month adj. EBITDA $191.5M (+10.4%).
FY2022 guidance: net sales $1.39-$1.42B, adj. EBITDA $262-$268M (growth 11-14% and 12-15% vs FY2021).
Repurchased 0.1M shares for $2.4M in Q3; $47.6M remaining under authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.